X0202 SCHEDULE 13G/A 0002059960 XXXXXXXX LIVE 4 Common Stock, par value $0.0001 per share 06/30/2026 0001859807 Profusa, Inc. 74319X207 626 Bancroft Way, Suite A Berkeley CA 94710 Rule 13d-1(c) Ascent Partners Fund LLC a DE 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 OO The percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share, of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount (as defined in this footnote), the shares of Common Stock to be issued upon (a) conversions of convertible promissory notes (the "Convertible Notes"), effective April 20, 2026, April 2, 2026, July 11, 2025 and December 29, 2023 respectively, held directly by the reporting person and (b) purchases by the reporting person pursuant to that certain Securities Purchase Agreement, dated as of July 28, 2025 and amended on December 22, 2025, between the issuer and the reporting person (the "ELOC Agreement") whereby, subject to certain conditions, the issuer may, at its option but subject to the Blocker Amount, require the reporting person to purchase Common Stock. The Convertible Notes and ELOC Agreement are all subject to a maximum 9.99% beneficial ownership limitation contained therein (the "Blocker Amount"). In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on May 26, 2026 (the "Definitive Proxy Statement") and as adjusted for the one-for-twenty-five (1:25) reverse stock split the Company effected on July 7, 2026 (the "Reverse Stock Split") and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes, and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Ascent Partners LLC a DE 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 OO The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Note and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Dominion Capital LLC a CT 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 OO The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Dominion Capital GP LLC a DE 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 OO The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Eagle Claw Corp. a DE 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 OO The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Masada Group Holdings LLC a FL 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 OO The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Mikhail Gurevich a X1 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 HC IN The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Gennadiy Gurevich a X1 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 HC IN The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Alon Brenner a X1 0.00 58749.00 0.00 58749.00 58749.00 N 9.99 HC IN The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount. Profusa, Inc. 626 Bancroft Way, Suite A, Berkeley, CA 94710 (i) Ascent Partners Fund LLC, a Delaware limited liability company ("Ascent"); (ii) Ascent Partners LLC, a Delaware limited liability company ("AP"); (iii) Dominion Capital LLC, a Connecticut limited liability company ("Dominion"); (iv) Dominion Capital GP LLC, a Delaware limited liability company ("Dominion GP"); (v) Eagle Claw Corp., a Delaware corporation ("Eagle Claw"); (vi) Masada Group Holdings LLC, a Florida limited liability company ("Masada"); (vii) Mikhail Gurevich; (viii) Gennadiy Gurevich; and (ix) Alon Brenner. The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to Amendment 3 to this Schedule 13G filed with the SEC on June 5, 2026, pursuant to which such Reporting Persons have agreed to file this Schedule 13G and all subsequent amendments to the Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act. The filing of this Schedule 13G should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of Common Stock reported herein. 19505 Biscayne Blvd., Suite 2350, Aventura, FL 33180 Each of Ascent, AP, and Dominion GP is a Delaware limited liability company. Eagle Claw Corp. is a Delaware corporation. Dominion is a Connecticut limited liability company. Masada is a Florida limited liability company. Each of Mikhail Gurevich, Gennadiy Gurevich, and Alon Brenner is a citizen of the United States. Y The information required by this item with respect to each reporting person is set forth on rows (5) through (9) and (11) of the cover page to this Schedule 13G and is incorporated herein by reference for each such reporting person. The ownership percentages reported are based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on May 26, 2026 and as adjusted for the one-for-twenty-five (1:25) reverse stock split the Company effected on July 7, 2026 and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, each subject to a provision contained therein limiting beneficial ownership to an aggregate maximum of 9.99% (the "Blocker"). Due to the Blocker, Ascent is currently prohibited from fully converting the Convertible Notes into shares of Common Stock or purchasing all of the shares purchasable pursuant to the ELOC Agreement. The percentage set forth on row (11) and the number of shares of Common Stock set forth on rows (5) through (9) of the cover page for each reporting person give effect to the Blocker in the Convertible Note. Consequently, as of June 30, 2026, each of the reporting persons are not deemed to be beneficial owners of the full amount of shares of Common Stock issuable upon conversion of the First Convertible Note or purchasable pursuant to the ELOC Agreement. As of June 30, 2026, Ascent did not directly hold any shares. In addition, as of June 30, 2026, (i) there are 58,749 shares of Common Stock underlying the Convertible Notes, with such amount being the maximum issuable up to the Blocker. The shares held directly by Ascent and the remaining shares issuable (up to the Blocker) pursuant to the Convertible Notes are collectively referred to herein as the "Shares". Gennadiy Gurevich is the President of Eagle Claw. Mikhail Gurevich is the Chief Investment Officer of Eagle Claw. In these capacities, each of Mikhail Gurevich and Gennadiy Gurevich manages Eagle Claw, Dominion GP, Dominion Capital, AP and Ascent. Eagle Claw manages Dominion GP, Dominion Capital, AP and Ascent. Dominion GP manages Dominion Capital, AP and Ascent. Dominion Capital manages AP and Ascent. Alon Brenner manages Masada, AP and Ascent. Masada manages AP and Ascent. AP manages Ascent. Ascent has the power to dispose of and the power to vote the shares of Common Stock beneficially owned by it. Each of Mikhail Gurevich, Gennadiy Gurevich, Eagle Claw, Dominion GP, Dominion, Alon Brenner, Masada and AP may be deemed to beneficially own, and have the power to vote, the shares of Common Stock beneficially owned by Ascent and the other companies they are listed above as managing. 9.99% 0 58,749 0 58,749 Y Y Y N See Exhibit 1 hereto. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. Ascent Partners Fund LLC /s/ Ascent Partners Fund LLC 08/04/2026 Ascent Partners LLC /s/ Ascent Partners LLC 08/04/2026 Dominion Capital LLC /s/ Dominion Capital LLC 08/04/2026 Dominion Capital GP LLC /s/ Dominion Capital GP LLC 08/04/2026 Eagle Claw Corp. /s/ Eagle Claw Corp. 08/04/2026 Masada Group Holdings LLC /s/ Masada Group Holdings LLC 08/04/2026 Mikhail Gurevich /s/ Mikhail Gurevich 08/04/2026 Gennadiy Gurevich /s/ Gennadiy Gurevich 08/04/2026 Alon Brenner /s/ Alon Brenner 08/04/2026 LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated June 5, 2026 (incorporated by reference to Exhibit 1 to the Schedule 13G/A filed by the Reporting Persons with the SEC on June 5, 2026)